Rockwell Automation Launches PharmaSuite 12.00 to Accelerate Secure, Scalable Deployments

Rhea-AI Summary

Rockwell Automation (NYSE: ROK) has launched FactoryTalk PharmaSuite 12.00, an enhanced manufacturing execution system (MES) designed for pharmaceutical and biopharmaceutical manufacturing. The new release features cloud-ready capabilities and a modular architecture to address key industry challenges including high costs, slow implementation, and flexibility limitations.

Key features include: cloud-based deployment using Kubernetes and Linux containers, a new setup tool (MICKA) for automated installation, modular design for scalability, built-in monitoring tools, enhanced cybersecurity, and simplified upgrade processes. The system aims to help manufacturers scale operations faster, simplify global rollouts, and reduce validation time and costs while maintaining regulatory compliance.

Positive

• Introduction of cloud-based deployment capabilities using Kubernetes for faster setup and maintenance
• New automated setup tool (MICKA) reduces manual effort in regulated environments
• Enhanced cybersecurity features meeting industry standards
• Modular design enables easier scaling across multiple sites

Negative

• None.

News Market Reaction

+2.91%

1 alert

+2.91% News Effect

On the day this news was published, ROK gained 2.91%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Latest MES release helps pharmaceutical and biopharmaceutical manufacturers simplify system management, improve flexibility and speed time-to-value

MILWAUKEE, May 13, 2025 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced the launch of FactoryTalk® PharmaSuite® 12.00. The latest release of its manufacturing execution system (MES) is designed to support the unique needs of regulated pharmaceutical and biopharmaceutical manufacturing environments, helping companies simplify system management, accelerate deployments and scale production more efficiently.

As the industry seeks to move faster while ensuring compliance, BioPhorum has noted that current MES solutions are often perceived as expensive, slow to implement and lacking flexibility required for modern operations. PharmaSuite 12.00 directly addresses these pain points, providing a simplified, configurable and future-ready platform for regulated life sciences production.

The latest release introduces a modular architecture and new cloud-ready capabilities, providing manufacturers with increased agility to help meet rapidly evolving production demands. It also features enhanced cybersecurity to support the stringent compliance and data integrity standards required in regulated life sciences environments.

"PharmaSuite 12.00 represents a major step forward in helping life sciences manufacturers embrace modular, digital production while maintaining the highest standards of performance, availability, compliance and security," said Martin Petrick, business manager, MES at Rockwell Automation. "With the flexibility to deploy in the cloud, on-premises or in hybrid models, manufacturers can scale operations faster, simplify global rollouts and reduce the time and cost validation."

 Key new features in FactoryTalk PharmaSuite 12.00 include:

• Cloud-Based Deployment: Now runs in Kubernetes using Linux containers, making setup and maintenance faster and more reliable
• New Setup Tool (MICKA): Automates installation and validation steps to reduce manual effort in regulated environments
• Modular Design: Containerized components make it easy to scale across sites and standardize system deployments
• Built-in Monitoring: Centralized tools help detect issues early and speed up troubleshooting
• Strong Cybersecurity: Built using certified secure development practices to meet industry standards
• Easier Upgrades: A new upgrade engine helps keep systems current with the latest features and security updates

FactoryTalk PharmaSuite 12.00 builds on more than 15 years of continuous development and industry expertise. With this release, Rockwell continues to provide pharmaceutical and biopharmaceutical manufacturers with a modern, regulatory-compliant MES platform that supports scalable production, rapid deployment and digital transformation goals.

Click here to learn more about FactoryTalk PharmaSuite. 

About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 27,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2024. To learn more about how we are bringing the Connected Enterprise® to life across industrial enterprises, visit www.rockwellautomation.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rockwell-automation-launches-pharmasuite-12-00-to-accelerate-secure-scalable-deployments-302453073.html

SOURCE Rockwell Automation, Inc.

FAQ

What are the key features of Rockwell Automation's PharmaSuite 12.00?

PharmaSuite 12.00's key features include cloud-based deployment using Kubernetes, automated setup tool MICKA, modular design for scalability, built-in monitoring, enhanced cybersecurity, and simplified upgrade processes.

How does PharmaSuite 12.00 benefit pharmaceutical manufacturers?

It helps manufacturers scale operations faster, simplify global rollouts, reduce validation time and costs, while maintaining regulatory compliance through enhanced cybersecurity and automated processes.

What deployment options does ROK's PharmaSuite 12.00 offer?

PharmaSuite 12.00 offers flexible deployment options including cloud-based, on-premises, or hybrid models, running on Kubernetes using Linux containers.

How does PharmaSuite 12.00 address cybersecurity concerns?

The system is built using certified secure development practices to meet industry standards and includes enhanced cybersecurity features to support compliance and data integrity in regulated environments.